Live-cell analysis instruments for drug discovery and cell therapy R&D
Axion BioSystems manufactures benchtop and incubator-integrated instruments for continuous, label-free monitoring of cell behavior in vitro. The tech stack (Python, C/C++, VHDL/Verilog, Azure, GitHub Actions) reflects embedded firmware and real-time data acquisition at the core of hardware development. Active hiring is concentrated in mid-level engineering roles across US, UK, India, and Gibraltar, paired with projects in bioinstrumentation and manufacturing tooling—suggesting scaling of both product development and production capacity.
Axion BioSystems develops live-cell analysis hardware for academic, biotech, and pharmaceutical labs. The product line includes the Maestro multielectrode array (MEA) system for electrophysiology, the Maestro Z analyzer for real-time cell monitoring, and the Omni imager for automated imaging—all designed for continuous noninvasive measurement without labels. The company serves neurology, cardiology, immunotherapy, and antiviral research workflows. With more than 180 employees globally and headquarters in Atlanta, Axion operates across R&D, manufacturing, and customer support.
Embedded firmware in C/C++, VHDL, and Verilog for real-time data acquisition; Python for analysis; cloud infrastructure on Azure; and hardware design in Altium Designer.
Atlanta, Georgia, USA. The company employs over 180 people worldwide and operates in the tech and biotech hub.
Other companies in the same industry, closest in size